R&D

Research and Development is a strategic pillar for Corman Pharmaceuticals, forming the basis of its innovation - driven approach to product development. Every stage - from concept to licensing - is guided by scientific rigor and operational precision.

R&D and product development processes are precisely planned and executed, covering formulation development, bioavailability and bioequivalence studies, as well as preclinical and clinical trials. These activities are managed by Corman’s expert team in collaboration with trusted strategic partners.

The company works with both domestic and international solution providers to deliver project-specific, innovative approaches. Core capabilities include pharmaceutical biotechnology, pharmacokinetic analysis, high-resolution chromatography, pharmaceutical stability studies, and technology transfer.

In all manufacturing operations, Corman prioritizes quality, efficacy, bioavailability, and full regulatory compliance. Each solution is customized to meet the unique requirements of the product, with particular attention to building strong safety profiles, analyzing clinical data, and executing the licensing process in full.